US Patent 9125889 Use of inhibitors of Bruton's tyrosine kinase (Btk)
Patent 9125889 was granted and assigned to Pharmacyclics on September, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9125889 Use of inhibitors of Bruton's tyrosine kinase (Btk)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
